Founded in March 2002 and listed on the Shanghai Stock Exchange in 2017 (Stock Code: 603387), Getein Biotech, Inc. was the first company in China's Point-of-Care Testing (POCT) field to be listed on the main board. Getein focuses on the research and development (R&D), production, sales, and service of in vitro diagnostic reagents and instruments. Getein's core competitiveness is anchored in eight major technology platforms. These encompass Point-of-Care Testing (POCT), Chemiluminescence, Clinical Chemistry, Coagulation, Hematology, Molecular Diagnostics, and Veterinary Diagnostics, complemented by the R&D of Quality Control Solutions.

Getein's evolution has taken it from an initial focus on traditional, low-throughput immunofluorescence products to a diversified portfolio. This portfolio now features multi-technology platforms and fully automated, high-throughput systems, including Integrated Hematology, Immunochemistry and Clinical Chemistry Modular System, and Integrated Clinical Chemistry and Immunochemistry Modular System. Its comprehensive test menu spans a wide spectrum of clinical areas, including Cardiovascular Disease, Inflammation, Diabetes, Renal Function, Thyroid Function, Infectious Diseases, Hormones, Bone Metabolism, and Tumor Markers.

Getein has obtained multiple authoritative certifications including ISO9001:2015, ISO13485:2016, MDSAP and IVDR, complying with the compliance and market access requirements of major global regulatory authorities such as the US FDA, Health Canada (HC), Brazil ANVISA, Australia TGA and Japan MHLW. As of the end of 2025, the company has acquired a total of 4,420 product registration certificates, among which 476 are domestic certificates (37 Class III medical devices, 388 Class II medical devices and 51 Class I medical devices), and 3,944 are overseas registration certificates (covering import permits issued by 67 countries and regions), laying a solid compliance foundation for the company's global strategic layout.

After years of in-depth industry cultivation and market accumulation, Getein has established long-term and stable partnerships with more than 3,000 high-quality distributors nationwide and over 400 overseas distributors. It has built an extensive and solid distribution network. Supported by the well-established channel system, its products are sold to 130 countries and regions across the globe.